We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$20.7M
Cap. Flow
+$5.39M
Cap. Flow %
1.83%
Top 10 Hldgs %
28.09%
Holding
92
New
25
Increased
25
Reduced
19
Closed
18

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$4.59M
2
ZTS icon
Zoetis
ZTS
+$4.07M
3
TMO icon
Thermo Fisher Scientific
TMO
+$3.62M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.97M
5
SYK icon
Stryker
SYK
+$2.87M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$9.28M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.79M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.91M
4
MRK icon
Merck
MRK
+$4.77M
5
CAH icon
Cardinal Health
CAH
+$3.9M

Sector Composition

Rank Sector Weight
1 Healthcare 86.68%
2 Financials 2.98%
3 Energy 1.23%
4 Industrials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
76
HCA Healthcare
HCA
$89.1B
– –
-35,000
Closed -$3.05M
JNJ icon
77
Johnson & Johnson
JNJ
$624B
– –
-70,000
Closed -$9.28M
MDT icon
78
Medtronic
MDT
$115B
– –
-35,000
Closed -$3.11M
MRK icon
79
Merck
MRK
$321B
– –
-78,600
Closed -$4.77M
REGN icon
80
Regeneron Pharmaceuticals
REGN
$83.1B
– –
-10,000
Closed -$4.91M
SAGE
81
DELISTED
Sage Therapeutics
SAGE
– –
-20,000
Closed -$1.59M
UHS icon
82
Universal Health Services
UHS
$10B
– –
-25,000
Closed -$3.05M
ENDP
83
DELISTED
Endo International plc
ENDP
– –
-250,000
Closed -$2.79M
DPLO
84
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
– –
-120,000
Closed -$1.78M
BCR
85
DELISTED
CR Bard Inc.
BCR
– –
-5,000
Closed -$1.58M
1 2 3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q3 2017 Portfolio in Review

As of Q3 2017, Sivik Global Healthcare held 92 positions worth $294M, up 7.6% from $273M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare's Q3 2017 filing shows 25 new, 25 increased, 19 reduced and 18 closed positions. Its largest new stake was Danaher: 62,040 shares worth $4.72M. The largest sale was Johnson & Johnson, an estimated $9.28M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 88% a quarter earlier, followed by Financials and Energy.

  • Sivik Global Healthcare's largest Q3 2017 buy was Danaher: 62,040 shares worth $4.72M.
  • Sivik Global Healthcare added most to Thermo Fisher Scientific in Q3 2017, an estimated $3.62M increase.
  • Sivik Global Healthcare's biggest Q3 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $6.79M.
  • Sivik Global Healthcare fully exited Johnson & Johnson in Q3 2017, selling an estimated $9.28M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $294M portfolio in Q3 2017.
  • Sivik Global Healthcare opened 25 new positions and closed 18 in Q3 2017.
  • Sivik Global Healthcare's portfolio value rose 7.6% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q3 2017, filed 8 Nov 2017.